Clinical Trial

Study of Cerebral Vascular Reserve Using Pharmacological Testing With Acetazolamide: A Non-Inferiority Study of PET Method Compared to Conventional Reference Scintigraphy

Study acronym: DIAMOX-TEP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study compares two methods for assessing brain blood flow. PET scan will be use with a drug called Acetazolamide and compare its effectiveness to the standard scintigraphy method. The goal is to see if the PET scan is just as good as the traditional method in measuring how well the brain's blood vessels respond to the drug.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-02.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-04-29
Trial Details
NCT Number NCT06584747
Lead Sponsor Centre Antoine Lacassagne
Conditions Cerebrovascular Circulation
Enrollment 19 participants
Start Date 2025-01-09
Primary Completion 2027-04-09 (estimated)
Study Completion 2027-04-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-05